PT1303506E - 6-heteroarilfenantridinas - Google Patents
6-heteroarilfenantridinasInfo
- Publication number
- PT1303506E PT1303506E PT01962844T PT01962844T PT1303506E PT 1303506 E PT1303506 E PT 1303506E PT 01962844 T PT01962844 T PT 01962844T PT 01962844 T PT01962844 T PT 01962844T PT 1303506 E PT1303506 E PT 1303506E
- Authority
- PT
- Portugal
- Prior art keywords
- heteroatoms
- unsubstituted
- radical
- substituted
- pyradazinyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/08—Antiseborrheics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- Dermatology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Pulmonology (AREA)
- Cardiology (AREA)
- Pain & Pain Management (AREA)
- Heart & Thoracic Surgery (AREA)
- Communicable Diseases (AREA)
- Rheumatology (AREA)
- Oncology (AREA)
- Psychiatry (AREA)
- Virology (AREA)
- Hospice & Palliative Care (AREA)
- Tropical Medicine & Parasitology (AREA)
- Gynecology & Obstetrics (AREA)
- Transplantation (AREA)
- Molecular Biology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Toxicology (AREA)
- AIDS & HIV (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP00115352 | 2000-07-14 | ||
| PCT/EP2001/007818 WO2002006270A1 (en) | 2000-07-14 | 2001-07-07 | Novel 6-heteroarylphenanthridines |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT1303506E true PT1303506E (pt) | 2005-06-30 |
Family
ID=8169276
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT01962844T PT1303506E (pt) | 2000-07-14 | 2001-07-07 | 6-heteroarilfenantridinas |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US6884802B2 (pt) |
| EP (1) | EP1303506B1 (pt) |
| JP (1) | JP2004504316A (pt) |
| AT (1) | ATE288430T1 (pt) |
| AU (2) | AU8393501A (pt) |
| CA (1) | CA2415935A1 (pt) |
| DE (1) | DE60108758T2 (pt) |
| DK (1) | DK1303506T3 (pt) |
| ES (1) | ES2236288T3 (pt) |
| PT (1) | PT1303506E (pt) |
| SI (1) | SI1303506T1 (pt) |
| WO (1) | WO2002006270A1 (pt) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2004018431A2 (en) * | 2002-08-17 | 2004-03-04 | Altana Pharma Ag | Novel phenanthridines |
| JP4587295B2 (ja) | 2002-08-29 | 2010-11-24 | ニコメッド ゲゼルシャフト ミット ベシュレンクテル ハフツング | Ｐｄｅ４インヒビターとしての３−ヒドロキシ−６−フェニルフェナントリジン |
| EP1736471B1 (en) | 2004-01-23 | 2014-01-08 | Mitsui Chemicals Agro, Inc. | 3-(dihydro(tetrahydro)isoquinolin-1-yl)quinolines |
| AU2005212857B2 (en) | 2004-02-18 | 2011-04-28 | Takeda Gmbh | Novel guanidinyl-substituted hydroxy-6-phenylphenenthridines as effective phosphodiesterase (PDE) 4 inhibitors |
| AR049419A1 (es) * | 2004-03-03 | 2006-08-02 | Altana Pharma Ag | Hidroxi-6-fenilfenantridinas sustituidas con heterociclilo |
| EA017282B1 (ru) * | 2004-03-03 | 2012-11-30 | Никомед Гмбх | Производное гидрокси-6-гетероарилфенантридина и его применение в качестве ингибитора pde4 |
| US20070185149A1 (en) * | 2004-03-10 | 2007-08-09 | Altana Pharma Ag | Novel amido-substituted hydroxy-6-phenylphenanthridines and their use as pde4 inhibtors |
| EA200701815A1 (ru) * | 2005-03-02 | 2008-02-28 | Никомед Гмбх | 6-гетероарил-1,2,3,4,4а,10в-гексагидрофенантридины в качестве pde-4 ингибиторов для лечения воспалительных заболеваний |
| ME01172B (me) | 2005-03-02 | 2013-03-20 | Takeda Gmbh | (2r,4ar,10br)-6-(2,6-dimetoksipiridin-3-il)-9-etoksi-8-metoksi-1,2,3,4,4a,10b-heksahidrofenantridin-2-ol, hci so |
| AU2008226844A1 (en) * | 2007-03-13 | 2008-09-18 | Merck Sharp & Dohme Corp. | Inhibitors of janus kinases and/or 3-phosphoinositide-dependent protein kinase-1 |
| NO340563B1 (no) * | 2016-09-05 | 2017-05-15 | Takeda Gmbh | Nye salter av 6-heterocyklylsubstituerte heksahydrofenantridinderivater |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE59709437D1 (de) | 1996-01-31 | 2003-04-10 | Altana Pharma Ag | Neue phenanthridine |
| DK0889886T5 (da) | 1996-03-26 | 2003-02-24 | Altana Pharma Ag | Hidtil ukendte, i 6-stilling substituerede phenanthridiner |
| WO1999005111A1 (en) * | 1997-07-25 | 1999-02-04 | Byk Gulden Lomberg Chemische Fabrik Gmbh | Novel tetrazole derivatives |
| JP2001510827A (ja) | 1997-07-25 | 2001-08-07 | ビイク グルデン ロンベルク ヒエーミツシエ フアブリーク ゲゼルシヤフト ミツト ベシユレンクテル ハフツング | 置換６−フェニルフェナントリジン |
| AU9066498A (en) | 1997-07-25 | 1999-02-16 | Byk Gulden Lomberg Chemische Fabrik Gmbh | Substituted 6-alkylphenanthridines |
| AU2904300A (en) | 1999-01-15 | 2000-08-01 | Byk Gulden Lomberg Chemische Fabrik Gmbh | Polysubstituted 6-phenylphenanthridines with pde-iv inhibiting activity |
| EP1147103B1 (en) | 1999-01-15 | 2005-05-04 | ALTANA Pharma AG | Phenantrhridine-n-oxides with pde-iv inhibiting activity |
| US6479505B1 (en) | 1999-01-15 | 2002-11-12 | Altana Pharma Ag | 6-arylphenanthridines with PDE-IV inhibiting activity |
| AU2107700A (en) | 1999-01-15 | 2000-08-01 | Byk Gulden Lomberg Chemische Fabrik Gmbh | Phenanthridine-n-oxides with pde-iv inhibiting activity |
| EP1250325B1 (en) | 2000-01-11 | 2008-05-07 | Nycomed GmbH | Phenanthridine-n-oxides |
-
2001
- 2001-07-07 AU AU8393501A patent/AU8393501A/xx active Pending
- 2001-07-07 AU AU2001283935A patent/AU2001283935B2/en not_active Ceased
- 2001-07-07 DK DK01962844T patent/DK1303506T3/da active
- 2001-07-07 US US10/297,765 patent/US6884802B2/en not_active Expired - Fee Related
- 2001-07-07 SI SI200130330T patent/SI1303506T1/xx unknown
- 2001-07-07 CA CA002415935A patent/CA2415935A1/en not_active Abandoned
- 2001-07-07 DE DE60108758T patent/DE60108758T2/de not_active Expired - Fee Related
- 2001-07-07 JP JP2002512173A patent/JP2004504316A/ja active Pending
- 2001-07-07 WO PCT/EP2001/007818 patent/WO2002006270A1/en active IP Right Grant
- 2001-07-07 AT AT01962844T patent/ATE288430T1/de not_active IP Right Cessation
- 2001-07-07 PT PT01962844T patent/PT1303506E/pt unknown
- 2001-07-07 ES ES01962844T patent/ES2236288T3/es not_active Expired - Lifetime
- 2001-07-07 EP EP01962844A patent/EP1303506B1/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| AU2001283935B2 (en) | 2006-07-13 |
| US20040038979A1 (en) | 2004-02-26 |
| ES2236288T3 (es) | 2005-07-16 |
| CA2415935A1 (en) | 2002-01-24 |
| EP1303506A1 (en) | 2003-04-23 |
| DE60108758T2 (de) | 2006-04-27 |
| ATE288430T1 (de) | 2005-02-15 |
| SI1303506T1 (en) | 2005-06-30 |
| US6884802B2 (en) | 2005-04-26 |
| JP2004504316A (ja) | 2004-02-12 |
| DE60108758D1 (de) | 2005-03-10 |
| WO2002006270A1 (en) | 2002-01-24 |
| EP1303506B1 (en) | 2005-02-02 |
| AU8393501A (en) | 2002-01-30 |
| DK1303506T3 (da) | 2005-05-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE288430T1 (de) | 6-heteroarylphenanthridine | |
| YU46200A (sh) | N-(supstituisani peto-članog di-ili triaza dinezasićenog prstena)karbonil/guanidin derivati za tretiranje ishemije | |
| NL350077I2 (nl) | Cyprosulfamide | |
| NO20003233D0 (no) | 4-hydrokykinolin-3-karboksamider og hydraziner som antivirale midler | |
| BR0110704A (pt) | Fenil - acetamidas substituìdas e seu uso como ativadores de glicocinase | |
| PT1254135E (pt) | Compostos organicos | |
| BR0014526A (pt) | Compostos cìclicos de seis elementos contendo nitrogênio aromático | |
| DK0951473T3 (da) | Cyclosporinderivat, fremstilling af dette og farmaceutiske præparater indeholdende dette | |
| TR200102805T2 (tr) | Glikokinaz aktivatörleri | |
| CY1107539T1 (el) | Παραγωγα κουιναζολινης | |
| DE60111362D1 (de) | Stabilisierte ascorbinsäure-lösungen | |
| BR0111451A (pt) | Inibidores de serina protease | |
| TR199802767T2 (xx) | Trombin �nleyiciler olarak yeni amidino t�revleri. | |
| MXPA02010648A (es) | Formulaciones liquidas. | |
| EE200000322A (et) | Uued ühendid | |
| NO20020031L (no) | Dihydrobenzodiazepiner og deres anvendelse til behandling av dyslipidemi | |
| ATE367797T1 (de) | Verwendundung von rhamnolipiden als kosmetika | |
| ATE280169T1 (de) | Serotonerge benzothiophene | |
| NO20034171D0 (no) | Biguanidderivater | |
| ATE277031T1 (de) | Dihydrobenzofuranderivate verwendbar als entzündungshemmende mittel | |
| NO983531D0 (no) | Dihydrobenzofuranforbindelser anvendelig som antiinflammatoriske midler | |
| NO983528L (no) | Dihydrobenzofuran og relaterte forbindelser anvendelig som anti-inflammatoriske midler | |
| ATE263560T1 (de) | Neue verwendung von citreamicinen | |
| TW200506945A (en) | Storage circuit having single-ended write circuitry | |
| BR9812579A (pt) | Bloqueadores de canal de ca 2+ do tipo r de estado regular especìfico e seu uso |